Eaton Vance Tax-Advantage Global Dividend Opp (ETO) vs abrdn Life Sciences Investors (HQL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Eaton Vance Tax-Advantage Global Dividend Opp (ETO) has outperformed abrdn Life Sciences Investors (HQL) over the past year, losing 2.0% versus a loss of 8.5%. Over five years, ETO leads with a -11.7% price change compared with -22.8% for HQL. On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.3x vs 3.3x for Eaton Vance Tax-Advantage Global Dividend Opp).
abrdn Life Sciences Investors offers the higher dividend yield (12.42% vs 7.62%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ETO | HQL |
|---|---|---|
| Share price | $27.28 | $15.38 |
| Market cap | $447.07M | — |
| 1-day change | -3.88% | -3.81% |
| YTD return | -10.12% | -8.34% |
| 1-year return | -2.05% | -8.51% |
| 5-year return | -11.74% | -22.83% |
| P/E ratio (TTM) | 3.27 | 2.32 |
| EPS (TTM) | $8.33 | $6.64 |
| Dividend yield | 7.62% | 12.42% |
| Annual dividend | $2.08 | $1.91 |
| 52-week high | $32.35 | $22.67 |
| 52-week low | $25.68 | $15.35 |
| Distance from 52-week high | -15.67% | -32.16% |
| Analyst consensus | none | — |
| Average volume | 26.91K | 129.21K |
| Shares outstanding | 16.39M | — |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Eaton Vance Tax-Advantage Global Dividend Opp trades at a higher earnings multiple (3.3x vs 2.3x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (12.42% vs 7.62%).
About Eaton Vance Tax-Advantage Global Dividend Opp
ETO stock →Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund is a closed ended equity mutual fund launched and managed by Eaton Vance Management. It invests in public equity markets across the globe.
Finance · Investment Managers
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
ETO vs HQL FAQ
Which stock has performed better over the past year, ETO or HQL?
ETO returned -2.05% over the past 12 months, compared with -8.51% for HQL (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ETO or HQL?
HQL has the lower trailing P/E at 2.3, versus 3.3 for ETO. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Eaton Vance Tax-Advantage Global Dividend Opp or abrdn Life Sciences Investors?
abrdn Life Sciences Investors has the higher yield at 12.42%, compared with 7.62% for Eaton Vance Tax-Advantage Global Dividend Opp.
Are Eaton Vance Tax-Advantage Global Dividend Opp and abrdn Life Sciences Investors in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.